Replies to post #163981 on Biotech Values

[oc631]

GILD—Russia doesn’t require the same level of evidence for drug approvals as the US, EU, Japan, and China (among others). Russia is rather more like India, where the supporting data can be scant.

Right. And I think it's good policy to let the FDA and EMA handle the regulatory work.